Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancer Ruchika Sharma7 Sept 2025 4:15 PM ISTIndianapolis: Eli Lilly and Company has received Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for...
WHO Expands 2025 Essential Medicines List, Adding Life-Saving Cancer and Diabetes Treatments Medha Baranwal6 Sept 2025 9:00 AM ISTSwitzerland: The World Health Organization (WHO) has released the executive summary report of its 25th Expert Committee meeting on the Selection and...
Children with Type 1 Diabetes Face Increased Risk of Acute Leukemia, Study Finds Medha Baranwal6 Sept 2025 5:45 AM ISTFinland: Children diagnosed with type 1 diabetes mellitus (T1DM) may face an elevated risk of developing acute leukemia, particularly acute...
Elevated serum vitamin D levels are linked with higher skin cancer risk, finds study Dr. Kamal Kant Kohli3 Sept 2025 8:30 PM ISTSkin cancer, the most common global malignancy, is linked to ultraviolet (UV)-driven serum 25-hydroxyvitamin D (25(OH)D)synthesis, with its...
Combination therapy improves outcomes for advanced triple-negative breast cancer: Study Dr. Kamal Kant Kohli2 Sept 2025 9:15 PM IST A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy everolimus to standard...
Preterm Birth Risk Higher in Women Exposed to Childhood Cancer Therapy: Study Finds Medha Baranwal2 Sept 2025 9:00 PM ISTFrance: Pregnancy outcomes in cancer survivors are drawing growing attention-and a new study adds an important concern. Women exposed to chemotherapy...
Boehringer Ingelheim Hernexeos approved in China for previously treated patients with HER2-mutant advanced NSCLC Ruchika Sharma2 Sept 2025 10:50 AM ISTBoehringer Ingelheim has received approval for HERNEXEOS (zongertinib tablets) from China's National Medical Products Administration (NMPA) as...
Toripalimab-Based Cisplatin-Free Strategy Efficacious, safe in Advanced NPC: JAMA Dr Riya Dave1 Sept 2025 9:00 PM ISTResearchers have found in a phase 3 trial that toripalimab combination therapy without cisplatin proved feasible, offering high failure-free survival...
Study Finds No Clear Link Between Vitiligo and Cancer Risk Dr Riya Dave31 Aug 2025 11:00 PM ISTResearchers have discovered that patients with vitiligo, a chronic autoimmune skin disorder that occurs in 1-2% of the world's population, do not seem...
From Scan to Strategy: Study evaluates Impact of 3D CT and Virtual Endoscopy on Airway Management in Head and Neck Cancer Dr Monish Raut31 Aug 2025 9:30 PM ISTRecent study evaluates the impact of advanced airway assessment techniques-specifically 3D computed tomography (3D CT) reconstruction and virtual...
Cachexia index as a Biomarker for Cancer Cachexia and Quality of Life in Gastric Cancer: Study Dr Riya Dave29 Aug 2025 11:00 PM ISTResearchers have found in a new study that cachexia index (CXI) may be a valuable indicator for assessing cancer cachexia and health-related quality...
Pembrolizumab Significantly Improves Event-Free Survival in Head and Neck Cancer: NEJM Dr Riya Dave29 Aug 2025 10:15 PM ISTAccording to a recent study adding perioperative pembrolizumab to standard therapy such as surgery and radiotherapy with or without cisplatin...
